Rosnilimab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Rosnilimab, covering 2022-05-10 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA) [Phase 2]